Abstract This article provides a comparative analysis of the principles of legal regulation and the practice of using mechanisms for assessing potential risk when introducing genetically modified microorganisms (GMMs) into production in the Russian Federation and developed countries, such as the United States and countries in the European Union. It is shown how these rules affect the pace of development of biotechnology in these regions. The principles of assigning a qualified safety status to strains are discussed. The possibility of using the most successful provisions of these rules to improve the legislative framework related to the use of GMMs in the industry of the Russian Federation is being considered.

中文翻译：

---

美国、欧盟和俄罗斯联邦对基因工程改造微生物工业使用的法律法规比较分析

摘要 本文比较分析了俄罗斯联邦和美国等发达国家在将转基因微生物 (GMM) 引入生产时的法律监管原则和使用机制评估潜在风险的做法。欧洲联盟。展示了这些规则如何影响这些地区生物技术的发展速度。讨论了为菌株分配合格安全状态的原则。正在考虑使用这些规则中最成功的条款来改进与在俄罗斯联邦工业中使用 GMM 相关的立法框架的可能性。